We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




IVC Filters Tied to Higher Mortality in Seniors with PE

By HospiMedica International staff writers
Posted on 25 Dec 2018
Elderly patients with acute pulmonary embolism (PE) who receive an inferior vena cava (IVC) filter face a higher death risk, according to a new study.

Researchers at New York-Presbyterian Hospital/Columbia University Medical Center (NYP; New York, NY, USA), Universidad de Alcalá (Madrid, Spain), and Brigham and Women’s Hospital (BWH; Boston, MA, USA) conducted a study that examined data from 214,000 Medicare inpatient claims so as to evaluate the association between the use of IVC filters and mortality rates in older patients (mean age 77.8 years) who were hospitalized for acute PE. More...
Of these patients, 13.4% received an IVC filter.

The results revealed that patients that received an IVC filter had a higher 30-day mortality rate (11.6%) than those who did not receive a filter (9.3%). One-year mortality rates among those who survived longer than 30 days were higher in unadjusted analysis (20.5%) in the IVC filter group, compared to the non-IVC-filter group (13.4%). Results were similar in matched cohort analyses, where the IVC filter group had 61% higher odds for 30-day mortality and 2.19-fold increased odds for one-year mortality compared with the non-filter group. The study was published on December 10, 2018, in JAMA Internal Medicine.

“Until we obtain additional high-quality data from prospective (ideally randomized) studies, we caution against the overuse of IVC filters in the broad population of patients at-risk of venous thromboembolism (VTE),” said lead author Behnood Bikdeli, MD, of NYP. “There may be still a small subset of patients, including those with clinically important acute VTE and absolute contraindication for anticoagulation, or recurrent PE despite optimal anticoagulation, in whom use of IVC filters may be considered according to the expert guidelines.”

Since the invention of the permanent percutaneous IVC filter in 1973 and the retrievable IVC filter in the 1990s, its use has become a standard part of treatment for select patients with acute lower-extremity venous thrombosis who cannot receive anticoagulation. Placement of an IVC filter is thus frequently considered in trauma patients because of the high risk of VTE associated with traumatic injury and the risks of anticoagulation in this population. In recent years, the U.S. Food and Drug Administration (FDA) raised concerns about the safety of IVC filters, and some studies have indicated a temporal decrease in the use of this technology.

Related Links:
New York-Presbyterian Hospital/Columbia University Medical Center
Universidad de Alcalá
Brigham and Women’s Hospital


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.